'*Sent by Google Scholar Alerts (scholaralerts-noreply@google.com). Created by [fire](https://fire.fundersclub.com/).*\n\n---\n### \n\n### \n\n### [HTML] [Deep learning evaluation of echocardiograms to identi'
[{"title": "Prediction of ablation success using the features of an ECG and within patient variability between ECGs", "link": "https://pure.tue.nl/ws/portalfiles/portal/322351658/Dijkstra_V_1_.pdf", "details": "VC Dijkstra, RAJ Post, J Vermeer, LRC Dekker", "abstract": "The interest for this report was sparked by the research done by Attia and Noseworthy [1]. In this paper, they make use of an artificial intelligence model to predict, using an electrocardiogram (ECG) in sinus rhythm, whether the patient has \u2026"}, {"title": "Incidence of Newly Recognized Atrial Fibrillation in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten", "link": "https://www.heartrhythmjournal.com/article/S1547-5271\\(24\\)02382-8/abstract", "details": "M Castrichini, S Alsidawi, JB Geske, DB Newman\u2026 - Heart Rhythm", "abstract": "Mavacamten is a cardiac myosin inhibitor that has been shown to reduce left ventricular outflow tract obstruction in obstructive hypertrophic cardiomyopathy (oHCM). 1 In late-stage clinical trials, atrial fibrillation (AF) represented an adverse \u2026"}]
